Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Insulin Insitu-gel for Persistent Suppurative Otitis Media
NCT07535827Phase 1Completed
- Sponsor
- Deraya University
- Start
- Mar 2026
- Primary completion
- May 2026
- Countries
- 1
01
Overview
Phase 1, randomised trial in tympanic membrane perforation and chronic suppurative otitis media (CSOM) comparing insulin insitu gel with placebo group (2 arms). Primary endpoints: Perforation size at 1 month and Perforation healing signs at 2 months. Started Mar 2026; status: completed.
02
Drugs
human insulin
03
Conditions
tympanic membrane perforationchronic suppurative otitis media (CSOM)
Beyond the preview
Go deeper on NCT07535827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07535827.